MktsMarkets

Vivos Therapeutics, Inc.
NASDAQ: VVOSKey statistics
VVOS News
Stories mentioning VVOS from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 5,141 | 3,824 | 6,783 | 3,820 | 3,016 | 3,698 | 3,860 | 4,054 |
| Cost of Goods Sold | ||||||||
| Gross Profit | 3,059 | 2,986 | 3,937 | 2,110 | 1,509 | 2,097 | 2,334 | 2,651 |
| Operating Expenses | ||||||||
| Research & Development | ||||||||
| Sales General & Admin | ||||||||
| Total Operating Expenses | 9,674 | 9,363 | 8,671 | 6,975 | 5,427 | 4,902 | 4,979 | 4,587 |
| Operating Income (Loss) | (6,615) | (6,377) | (4,734) | (4,865) | (3,918) | (2,805) | (2,645) | (1,936) |
| Interest Income | ||||||||
| Interest Expense | 1,100 | 500.00 | ||||||
| Other Expense | (1,167) | (635.00) | (679.00) | (163.00) | (4.00) | (69.00) | (18.00) | (22.00) |
| Pretax Income | (7,751) | (6,953) | (5,400) | (5,013) | (3,864) | (2,827) | (2,616) | (1,930) |
| Tax Provision | ||||||||
| Net Income (Loss) | (7,682) | (6,893) | (5,400) | (5,013) | (3,864) | (2,827) | (2,616) | (1,930) |
| Earnings Per Share (Basic) | (0.52) | (0.67) | (0.49) | (0.55) | (0.45) | (0.56) | (0.40) | (0.60) |
| Earnings Per Share (Diluted) | (0.52) | (0.67) | (0.49) | (0.55) | (0.45) | (0.56) | (0.40) | (0.60) |
| Weighted Average Shares Outstanding (Basic) | 14,634 | 10,274 | 10,964 | 9,087 | 8,595 | 5,020 | 6,615 | 3,228 |
| Weighted Average Shares Outstanding (Diluted) | 14,634 | 10,274 | 10,964 | 9,087 | 8,595 | 5,020 | 6,615 | 3,228 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About VVOS
Vivos Therapeutics, Inc. (NASDAQ: VVOS) is a stock listed on the Nasdaq Stock Market under the ticker symbol VVOS. It last traded at $0.0900 (Nov 6, 2026, 4:00 PM ET), down 8.7% on the day. That gives Vivos Therapeutics a market capitalisation of $3.1M.
Over the past 52 weeks VVOS has traded between $0.0900 and $2.72.
Revenue for the quarter ended Mar 31, 2026 was $5.1M; a net loss of $7.7M. Revenue was up 70.5% from $3.0M in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $5.1M | -$7.7M | -149.4% |
| Dec 31, 2025 | $3.8M | -$6.9M | -180.3% |
| Sep 30, 2025 | $6.8M | -$5.4M | -79.6% |
| Jun 30, 2025 | $3.8M | -$5.0M | -131.2% |
From Vivos Therapeutics’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…